CHMP Agenda, page-2

Rev - have you forgotten your own post?

Revreboot - October CHMP Meeting (EMEA/H/D/002831), ((substance to be reviewed) insulin-like growth factor-i (igf-i) segment), (hard-to-heal wounds, primarily venous leg ulcers) List of Questions adopted on 23.01.2014. List of Outstanding Issues adopted on 25.09.2014. • Request from the applicant for an additional extension of clock stop to respond to the List of Outstanding Issues adopted in September 2014: For adoption.

The applicant for the extension of the clock stop was TIS and not the EMA nor the BIS nor Big Pharma.

That does mean TIS has asked for it and not the other way round as you imply - for further details see the thread you started: "EMA fails to follow its own legislation".